Page 34 - ITPS-6-2
P. 34

INNOSC Theranostics and
            Pharmacological Sciences                                           Residual versus curative antimalarial tests




            Table 3. In vivo curative antimalarial activity of the aqueous and organic extracts of Morinda lucida in Plasmodium
            berghei‑infected mice
             Plant part      Extract       Dose (mg/kg)  Parasite density (%)  Chemosuppression (%)  Mean survival time (days)
            Leaves          H O               100          76.70±3.37         −11.45            10.20±1.64
                             2
                                              250          55.98±0.41         18.66              9.40±1.52
                                              400          77.89±2.00         −13.17            10.60±1.95
            Positive control  Chloroquine      5           2.01±1.75*         97.08             18.20±4.82*
            Negative control  Distilled H O  0.2 mL        68.83±3.68          0.00             11.20±2.75
                                   2
            Leaves          Organic           100          81.93±1.45         −7.70              9.0±1.87
                                              250          74.08±2.24          2.61              8.60±1.34
                                              400          65.13±1.5          14.38              9.75±4.19
            Positive control  Chloroquine      5           6.24±0.66*         91.80             14.8±2.59*
            Negative control  Tween 80        0.2L          76.07±0            0.00              9.8±2.68
            Stem bark       H O               100         49.67±2.54*         43.45              9.40±2.19
                             2
                                              250          80.86±0.46          7.93              8.00±0.00
                                              400         68.79±22.75         21.67              9.00±1.87
            Positive control  Chloroquine      5           0.96±1.17*         98.91             14.20±4.09*
            Negative control  Distilled H O  0.2 mL        87.82±8.67          0.00              8.20±1.64
                                   2
            Stem bark       Organic           100            N/A              17.79              7.20±1.10
                                              250          81.35±2.77          0.55              8.20±1.64
                                              400         28.88±7.51*         51.14               8.00±0
            Positive control  Chloroquine      5           1.06±0.80*         98.71             11.80±1.30*
            Negative control  Tween 80       0.2 mL       81.79±13.42          0.00              7.80±0.45
            Notes: *Indicates significant difference from control, P≤0.05. Chemosuppression: ≥60%, high activity; 30 – 60%, moderate activity; <30%, weak
            activity; 0%, inactivity .
                          [13]
            found to be dose-dependent. Among the L. inermis-treated   activity, 21  showing  weak  activity, and  5 being inactive
            groups, the highest MST recorded was 10.50 ± 2.3 days,   (Tables 8-12). Although the survival time in most of the
            while the positive and negative control groups had MST   experimental groups was higher than that of the negative
            of 14.80 ± 2.95 and 9.00 ± 0.00 days, respectively (Table 6).  controls, the differences were not statistically significant (P
                                                               < 0.05) (Figure 3). In contrast to the suppressive and curative
            3.2.1.5 C. odorata
                                                               tests, chloroquine did not demonstrate a high percentage
            C. odorata exhibited activity ranging from weak and   chemoprophylaxis (PCP). Its activity ranged from weak to
            moderate. In the 400 mg/kg group of the aqueous extract,   inactive on D , which was reflected in the survival days of
                                                                          8
            most of the mice died before the end of the experiment   the group. Aqueous extracts exhibited better antimalarial
            (Table 7). The MST in the C. odorata-treated P. berghei-  prophylactic properties, with 2 out of the 21 doses showing
            infected mice ranged from 8.00 ± 0 to 10.50 ± 1.75 days,   high activity, 12 being moderate, and 7 displaying weak
            while the positive and negative control groups had MST   activity. On the other hand, the DCM-MeOH (1:1) extracts
            between 14.67  ± 1.15 to 14.80 ± 2.95 days and 8.00 ± 0.0 to   showed a dose with high activity, 7 with moderate activity,
            8.67 ±  0.58 days, respectively (Table 7).         10 with weak activity, and 3 without activity (Figure 3). The
                                                               activities elicited by selected medicinal plants are further
            3.2.2 Repository test results                      elaborated below.
            The residual antimalarial effects of the extracts were
            assessed on day 7 (D ) and 9 (D ) of the experiments. On   3.2.2.1 M. lucida
                                      8
                             6
            D , out of the 42 experimental groups (21 aqueous and   On D , both the DCM-MeOH (1:1) and aqueous leaf
                                                                    6
             6
            21 DCM-MeOH  : ), 3 groups exhibited high activity   extracts of M. lucida displayed activity ranging from weak
                           [1 1]
            (PCS>60%), 19 showed moderate activity, 17 groups had   (PCP = 18%) to moderate (PCP = 41.05%). While the
            weak activity, and 3 were inactive. However, on D , the   activity of the DCM-MeOH (1:1) extract groups decreased
                                                      8
            activities decreased, with 16 groups displaying moderate   on D , the activity of the aqueous extract groups increased,
                                                                   9
            Volume 6 Issue 2 (2023)                         7                         https://doi.org/10.36922/itps.0300
   29   30   31   32   33   34   35   36   37   38   39